Namir Khandker, MD, Author at Neurology Advisor

Thoughts on Brain Death: The Last Time I Felt Like a Healer

By

October 2, 2018

Finding the balance of empathy and professionalism is a skill that not enough of us recognize as essential, and even fewer seek to teach.

General Neurology

Brain Death: The Art of Explaining Ambiguity

By

Namir Khandker, MD

September 27, 2018

Attempting to engage on an intellectual level about the heady concept of brain death while in the throes of bereavement can often lead to mistrust and confusion.

Stroke

General Anesthesia a Viable Sedation Strategy for Thrombectomy in Stroke: Clinician Takeaway

By

Namir Khandker, MD

February 2, 2018

Although several studies have established the use of endovascular therapy with stent retrievers for selected acute stroke as standard of care, best practices surrounding the best sedation strategy remain unclear.

Stroke

ENCHANTED Update: No Role for Low-Dose Alteplase After All?

By

Namir Khandker, MD

October 19, 2017

Results from a secondary analysis of the ENCHANTED trial add to a pile of weak data that likely will not affect clinical practice.

Stroke

Expert Analysis: Tenecteplase Yet to Prove Itself vs Alteplase

By

Namir Khandker, MD

August 25, 2017

Despite disappointing results, tenecteplase’s story in stroke treatment might not be over.

Stroke

Pushing the Limits of Endovascular Therapy for Acute Ischemic Stroke

By

Namir Khandker, MD

November 29, 2016

Recent research found benefits in outcome outweighed any increase in hemorrhagic complications in patients with large infarcts.

Stroke

Glyburide Promising for Treatment of Acute Ischemic Stroke

By

Namir Khandker, MD

October 14, 2016

Although the study did not demonstrate efficacy of glyburide, differences were seen in the amount midline shift at 3-4 days.

Traumatic Brain Injury

Decompressive Craniectomy in Traumatic Brain Injury: Weighing the Risks and Benefits

By

Namir Khandker, MD

September 27, 2016

The greatest hurdle in developing effective treatments for TBI lies in the varied and dynamic pathophysiology and incomplete understanding of factors leading to poor outcome.